Thank you to everyone who joined us for G2 Intelligence’s first webinar since LabX Media Group took over the brand. The webinar, which ran live on April 27, featured a quick overview of G2 for those unfamiliar with the brand, an update on what has happened since LabX Media Group took over, as well as plans for the future of the brand. G2 editor/writer Glenn Demby finished off the presentation portion of the event with a summary of five key developments in lab compliance and reimbursement regarding:
- Imminent End of the Public Health Emergency (PHE)
- COVID-19 Fraud Crackdown
- FDA Regulation of Lab Developed Tests (LDTs)
- PAMA
- New OSHA Standard
At the conclusion of the event, the audience was ready with their questions for the Q&A portion of the webinar. Key questions focused on everything from what webinars we’re planning to do next to pricing of our products to questions on LDTs. If you missed the webinar, feel free to register to receive the recording once it’s available on demand.
If you have further questions or feedback on how we can improve our product that you weren’t able to ask during the webinar, be sure to reach out to rmuenz@g2intelligence.com.
We also hope to do these editor-reader Q&A sessions on a regular basis, so please let us know what you thought of the first session. What did you like? What would you change? We will continue to work on the format and content of these webinars as we go, so that they will best suit our audience’s needs. Thanks again!